Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros


Bases de dados
Tipo de estudo
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Clin Exp Immunol ; 120(3): 468-75, 2000 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-10844525

RESUMO

Although it has been shown that gammadelta T lymphocytes are able to react with different cell-associated or soluble antigens, the immune repertoire of these cells appears to be skewed to the recognition of mycobacterial antigens. We have studied the number and reactivity of gammadelta T cells towards several mycobacterial antigens in patients with tuberculosis and leprosy, as well as their healthy contacts and control individuals. We found an increased number of Vdelta2+ cells in healthy contacts (PPD+ and lepromin+) and tuberculoid leprosy patients. The gammadelta T cells from lepromatous leprosy showed a decreased response to all antigens tested, but some of these patients exhibited a significant response to the 30-kD glycoprotein of Mycobacterium tuberculosis. Interestingly, the reactivity of gammadelta T cells against mycobacterial antigens was significantly increased by costimulatory signals generated through CD7, LFA-1, CD50 and CD69 in all groups. However, signalling through CD69 did not enhance the responsiveness of gammadelta lymphocytes from lepromatous patients. On the other hand, the in vitro blockade of IL-10 with a specific antibody enhanced the cell proliferation of gammadelta lymphocytes from lepromatous leprosy patients, whereas exogenous IL-10 had an opposite effect in most individuals studied. These results suggest the potential role of different cell membrane receptors in the regulation of gammadelta T cell proliferation induced by mycobacteria, as well as the possible involvement of IL-10 in this phenomenon.


Assuntos
Antígenos de Bactérias/imunologia , Antígenos de Diferenciação , Mycobacterium/imunologia , Receptores de Antígenos de Linfócitos T gama-delta/imunologia , Transdução de Sinais , Linfócitos T/imunologia , Anticorpos Monoclonais , Antígenos CD/imunologia , Antígenos CD7/imunologia , Antígenos de Diferenciação de Linfócitos T/imunologia , Moléculas de Adesão Celular/imunologia , Divisão Celular , Separação Celular , Células Cultivadas , Citometria de Fluxo , Humanos , Interleucina-10/antagonistas & inibidores , Lectinas Tipo C , Ativação Linfocitária , Antígeno-1 Associado à Função Linfocitária/imunologia
2.
Immunol Lett ; 48(2): 123-28, 1995 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8719110

RESUMO

Our previous studies had shown that the clinicopathological spectrum in leprosy was associated with discrete T cell subsets in circulation, with tuberculoid patients having antigen-induced Th 1, whereas lepromatous leprosy patients with antigen-specific T cell anergy possessed Th 2 cells. The present study shows that infected monocytes from lepromatous but not tuberculoid leprosy patients released soluble factors (MoF(s)) containing IL-10 and PGE2 which inhibited M. leprae induced in vitro lymphoproliferation of previously sensitised healthy or tuberculoid leprosy subjects. A strong negative correlation was observed between adherent cell derived IL-10 and IL-2 at the level of both the product and cytokine mRNA. Moreover, anti-IL-10 antibodies and indomethacin partially reversed the suppressor effects of MoF(s). Taken together these studies indicate that infected monocytes contribute to the development of T cell anergy by releasing factors that affect regulatory cytokines and T cell subset differentiation in lepromatous leprosy.


Assuntos
Dinoprostona/fisiologia , Tolerância Imunológica , Interleucina-10/fisiologia , Hanseníase Virchowiana/imunologia , Linfopenia/imunologia , Monócitos/imunologia , Células Th1/imunologia , Anticorpos/farmacologia , Células Cultivadas , Dinoprostona/antagonistas & inibidores , Humanos , Tolerância Imunológica/efeitos dos fármacos , Indometacina/farmacologia , Interleucina-10/antagonistas & inibidores , Interleucina-10/imunologia , Ativação Linfocitária/efeitos dos fármacos , Monócitos/metabolismo , Células Th1/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA